StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ZURA

Zura Bio Limited

ZURA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$5.52
-0.02 -0.36%

Key statistics

from XBRL data in SEC filings
Market cap
$524M
Revenue (TTM)
Net income (TTM)
-$75.4M
EPS (TTM)
$-1.09
P/E ratio
Dividend yield
Free cash flow
-$64.9M
Cash
$226M
Total assets
$229M
Gross margin
52-week range
$1.39 – $7.44

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 1, 2026 8-K Director or officer change; Shareholder vote results Jun 18, 2026 8-K Director or officer change May 22, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change Apr 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 19, 2026 8-K Regulation FD disclosure Mar 10, 2026 8-K Regulation FD disclosure Mar 5, 2026 8-K/A FORM 8-K/A Feb 26, 2026 8-K Entered a material agreement; Results of operations (earnings release); Other events Feb 26, 2026 8-K Director or officer change; Regulation FD disclosure Feb 23, 2026 8-K Regulation FD disclosure Feb 11, 2026 8-K Director or officer change; Regulation FD disclosure Jan 26, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Other events Jan 2, 2026 8-K Director or officer change Dec 17, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Director or officer change Oct 10, 2025 8-K Director or officer change Sep 30, 2025 8-K Regulation FD disclosure Sep 4, 2025 8-K Regulation FD disclosure Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Director or officer change; Regulation FD disclosure Jul 1, 2025 8-K Regulation FD disclosure Jun 4, 2025 8-K Regulation FD disclosure May 27, 2025 8-K Shareholder vote results May 23, 2025 8-K Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 17, 2025 8-K Regulation FD disclosure Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 25, 2025 8-K Regulation FD disclosure Feb 24, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure Dec 23, 2024